Shedding light on optical cochlear implant progress

Kitcher, Siân R.; Weisz, Catherine

doi:10.15252/emmm.202012620

Cited by 3 publications

(1 citation statement)

References 9 publications

(12 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…An estimated 466 million individuals worldwide have disabling hearing loss (World Health Organization). 42 For patients with less severe hearing decline, hearing aids can be very effective. Hearing aids are functionally similar to an “audio amplifier”.…”

Section: Implantable Bioelectrodes For Medical Applicationsmentioning

confidence: 99%

Implantable bioelectrodes: challenges, strategies, and future directions

Hu,

Liang,

Wang

2024

Biomater. Sci.

View full text Add to dashboard Cite

show abstract

Section: Implantable Bioelectrodes For Medical Applicationsmentioning

confidence: 99%

Implantable bioelectrodes: challenges, strategies, and future directions

Hu,

Liang,

Wang

2024

Biomater. Sci.

View full text Add to dashboard Cite

show abstract

Bioengineering applications for hearing restoration: emerging biologically inspired and biointegrated designs

Brant¹,

Adewole²,

Vitale³

et al. 2021

Current Opinion in Biotechnology

View full text Add to dashboard Cite

Optogenetics: Illuminating the Future of Hearing Restoration and Understanding Auditory Perception

Singh,

Ramamourthy,

Hage

et al. 2024

CGT

View full text Add to dashboard Cite

Hearing loss is a prevalent sensory impairment significantly affecting communication and quality of life. Traditional approaches for hearing restoration, such as cochlear implants, have limitations in frequency resolution and spatial selectivity. Optogenetics, an emerging field utilizing light-sensitive proteins, offers a promising avenue for addressing these limitations and revolutionizing hearing rehabilitation. This review explores the methods of introducing Channelrhodopsin- 2 (ChR2), a key light-sensitive protein, into cochlear cells to enable optogenetic stimulation. Viral- mediated gene delivery is a widely employed technique in optogenetics. Selecting a suitable viral vector, such as adeno-associated viruses (AAV), is crucial in efficient gene delivery to cochlear cells. The ChR2 gene is inserted into the viral vector through molecular cloning techniques, and the resulting viral vector is introduced into cochlear cells via direct injection or round window membrane delivery. This allows for the expression of ChR2 and subsequent light sensitivity in targeted cells. Alternatively, direct cell transfection offers a non-viral approach for ChR2 delivery. The ChR2 gene is cloned into a plasmid vector, which is then combined with transfection agents like liposomes or nanoparticles. This mixture is applied to cochlear cells, facilitating the entry of the plasmid DNA into the target cells and enabling ChR2 expression. Optogenetic stimulation using ChR2 allows for precise and selective activation of specific neurons in response to light, potentially overcoming the limitations of current auditory prostheses. Moreover, optogenetics has broader implications in understanding the neural circuits involved in auditory processing and behavior. The combination of optogenetics and gene delivery techniques provides a promising avenue for improving hearing restoration strategies, offering the potential for enhanced frequency resolution, spatial selectivity, and improved auditory perception.

show abstract

Shedding light on optical cochlear implant progress

Cited by 3 publications

References 9 publications

Implantable bioelectrodes: challenges, strategies, and future directions

Implantable bioelectrodes: challenges, strategies, and future directions

Bioengineering applications for hearing restoration: emerging biologically inspired and biointegrated designs

Optogenetics: Illuminating the Future of Hearing Restoration and Understanding Auditory Perception

Contact Info

Product

Resources

About